Immunotherapy for non-small cell lung cancer: from clinical trials to real-world practice

被引：20

作者：

Rashdan, Sawsan ^{[1
,2
]}

Gerber, David E. ^{[1
,2
,3
]}

机构：

[1] Univ Texas Southwestern Med Ctr Dallas, Div Hematol Oncol, Dept Internal Med, 5323 Harry Hines Blvd,Mail Code 8852, Dallas, TX 75390 USA

[2] Univ Texas Southwestern Med Ctr Dallas, Harold C Simmons Comprehens Canc Ctr, Dallas, TX 75390 USA

[3] Univ Texas Southwestern Med Ctr Dallas, Dept Clin Sci, Dallas, TX 75390 USA

来源：

TRANSLATIONAL LUNG CANCER RESEARCH | 2019年 / 8卷 / 03期

关键词：

PHASE-II TRIAL; POOR PERFORMANCE STATUS; OPEN-LABEL; NIVOLUMAB; DOCETAXEL; ATEZOLIZUMAB; PEMBROLIZUMAB; PARTICIPATION; MULTICENTER; CARBOPLATIN;

D O I：

10.21037/tlcr.2018.09.15

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：202 / 207

页数：6

共 36 条

[1]

American Autoimmune Related Diseases Association Inc, AUT DIS STAT

[2]

Antonia SJ, 2018, NEW ENGL J MED, V378, P869, DOI 10.1056/NEJMc1716426

[3] Real world data of nivolumab for previously treated non-small cell lung cancer patients: a Galician lung cancer group clinical experience [J].

Areses Manrique, Ma Carmen ;

Mosquera Martinez, Joaquin ;

Garcia Gonzalez, Jorge ;

Afonso Afonso, Francisco Javier ;

Lazaro Quintela, Martin ;

Fernandez Nunez, Natalia ;

Azpitarte Raposeiras, Cristina ;

Amenedo Gancedo, Margarita ;

Santome Couto, Lucia ;

Garcia Campelo, Ma Rosario ;

Munoz Iglesias, Jose ;

Cortegoso Mosquera, Alexandra ;

Vilchez Simo, Rocio ;

Casal Rubio, Joaquin ;

Campos Balea, Begona ;

Carou Frieiro, Iria ;

Alonso-Jaudenes Curbera, Guillermo ;

Anido Herranz, Urbano ;

Garcia Mata, Jesus ;

Firvida Perez, Jose Luis .

TRANSLATIONAL LUNG CANCER RESEARCH, 2018, 7 (03) :404-415

[4] Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer [J].

Borghaei, H. ;

Paz-Ares, L. ;

Horn, L. ;

Spigel, D. R. ;

Steins, M. ;

Ready, N. E. ;

Chow, L. Q. ;

Vokes, E. E. ;

Felip, E. ;

Holgado, E. ;

Barlesi, F. ;

Kohlhaeufl, M. ;

Arrieta, O. ;

Burgio, M. A. ;

Fayette, J. ;

Lena, H. ;

Poddubskaya, E. ;

Gerber, D. E. ;

Gettinger, S. N. ;

Rudin, C. M. ;

Rizvi, N. ;

Crino, L. ;

Blumenschein, G. R. ;

Antonia, S. J. ;

Dorange, C. ;

Harbison, C. T. ;

Finckenstein, F. Graf ;

Brahmer, J. R. .

NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (17) :1627-1639

[5] Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer [J].

Brahmer, Julie ;

Reckamp, Karen L. ;

Baas, Paul ;

Crino, Lucio ;

Eberhardt, Wilfried E. E. ;

Poddubskaya, Elena ;

Antonia, Scott ;

Pluzanski, Adam ;

Vokes, Everett E. ;

Holgado, Esther ;

Waterhouse, David ;

Ready, Neal ;

Gainor, Justin ;

Aren Frontera, Osvaldo ;

Havel, Libor ;

Steins, Martin ;

Garassino, Marina C. ;

Aerts, Joachim G. ;

Domine, Manuel ;

Paz-Ares, Luis ;

Reck, Martin ;

Baudelet, Christine ;

Harbison, Christopher T. ;

Lestini, Brian ;

Spigel, David R. .

NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (02) :123-135

[6] Intracranial response to nivolumab in NSCLC patients with untreated or progressing CNS metastases [J].

Dudnik, Elizabeth ;

Yust-Katz, Shlomit ;

Nechushtan, Hovav ;

Goldstein, Daniel A. ;

Zer, Alona ;

Flex, Dov ;

Siegal, Tali ;

Peled, Nir .

LUNG CANCER, 2016, 98 :114-117

[7] Generalizability of cancer clinical trial results [J].

Elting, LS ;

Cooksley, C ;

Bekele, BN ;

Frumovitz, M ;

Avritscher, EBC ;

Sun, C ;

Bodurka, DC .

CANCER, 2006, 106 (11) :2452-2458

[8] Atezolizumab versus docetaxel for patients with previously treated non-small-cell lung cancer (POPLAR): a multicentre, open-label, phase 2 randomised controlled trial [J].

Fehrenbacher, Louis ;

Spira, Alexander ;

Ballinger, Marcus ;

Kowanetz, Marcin ;

Vansteenkiste, Johan ;

Mazieres, Julien ;

Park, Keunchil ;

Smith, David ;

Artal-Cortes, Angel ;

Lewanski, Conrad ;

Braiteh, Fadi ;

Waterkamp, Daniel ;

He, Pei ;

Zou, Wei ;

Chen, Daniel S. ;

Yi, Jing ;

Sandler, Alan ;

Rittmeyer, Achim .

LANCET, 2016, 387 (10030) :1837-1846

[9]

Franks AL, 2012, ANTICANCER RES, V32, P1119

[10] Pembrolizumab plus Chemotherapy in Metastatic Non-Small-Cell Lung Cancer [J].

Gandhi, L. ;

Rodriguez-Abreu, D. ;

Gadgeel, S. ;

Esteban, E. ;

Felip, E. ;

De Angelis, F. ;

Domine, M. ;

Clingan, P. ;

Hochmair, M. J. ;

Powell, S. F. ;

Cheng, S. Y. -S. ;

Bischoff, H. G. ;

Peled, N. ;

Grossi, F. ;

Jennens, R. R. ;

Reck, M. ;

Hui, R. ;

Garon, E. B. ;

Boyer, M. ;

Rubio-Viqueira, B. ;

Novello, S. ;

Kurata, T. ;

Gray, J. E. ;

Vida, J. ;

Wei, Z. ;

Yang, J. ;

Raftopoulos, H. ;

Pietanza, M. C. ;

Garassino, M. C. .

NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (22) :2078-2092

← 1 2 3 4 →